Request submitted to FDA to change the location of the treatment sessions from the Medical University of South Carolina (MUSC) to Dr. Mithoefer’s office. We propose renting a “crash cart” …
The Dutch government has announced a small scale cross over trial into the effect of three sorts of medical marijuana, plus a placebo, on 16 patients with multiple sclerosis. Two foundations in Rotterdam, …
Investigators: Dr. Spitzer, et al. University of Ulm, Germany Contact: This study was a double-blind, placebo-controlled investigation of the cognitive and brain activation effects of the isomers of MDE. …
Comment from Rick Doblin: The article reports that medical marijuana research is about to begin for the first time in nearly two decades. However, the article makes a distinction that readers are not likely …
DEA claimed the application was lost. Prof. Craker resubmitted a photocopy but was told in February 2002 that the photocopied application was invalid since it didn’t have an original signature. In …
"University of California at San Diego Gets Approval for Medical Marijuana Study" A California university has received final approval from the federal government for a study on medical marijuana. …
The fourth patient in the Spain MDMA/PTSD dose-response study was treated on November 28, 2001. We have now completed the 50 mgs dose group (3 patients received 50 mgs and 1 received a placebo). The next …
It’s my pleasure to report some excellent news. About 10 AM, Friday, November 2, FDA contacted me to say that MAPS’ MDMA/PTSD protocol was approved. This approval marks the culmination of 16 …
MAPS submitted to the FDA today the protocol for Dr. Michael Mithoefer and Dr. Mark Wagner’s MAPS-supported pilot study into the use of MDMA-assisted psychotherapy in the treatment of patients who …
As part of its submission to FDA of a protocol designed to study the use of MDMA in the treatment of PTSD, MAPS’ commissioned an extensive review of the scientific literature on MDMA. This literature …
A draft of the MDMA/PTSD protocol that MAPS has been working for 2 years to develop, with Dr. Michael Mithoefer and Mark Wagner, Ph.D., at the Medical University of South Carolina, has now been posted …
Prof. Craker files an application to the DEA for permission to grow research-grade marijuana for legal, privately funded research into the potential medicinal effects of marijuana.
